- About PRA
Since our inception in 1976, PRA has amassed a level of expertise that has enabled us to conduct complex global clinical trials across all therapeutic areas and provide outsourced clinical services across all phases of pharmaceutical and biotech drug development.
View a timeline of PRA's history.
This page will show you a map of all PRA locations and allow you to select the regions for details on our office locations.
Mission and Values
Our Mission: Our people commit to provide innovative solutions that our clients rely upon to introduce new drugs and to improve lives. Our Vision: We shall build a legacy of quality and trust.
PRA makes its financial information and reports available to holders of our Senior Notes and to any beneficial owners of the Senior Notes, as well as any prospective investors, securities analysts or market makers. The information is posted in a password-protected online data system and requires a signed eligibility letter.
PRA’s Therapeutic Expertise group is a scientific and medical expertise resource offered by PRA to provide clinical development support.
PRA has three fully equipped and harmonized bioanalytical laboratories: small and large molecule laboratories in Europe (Assen, The Netherlands) as well as a small molecule facility based in the United States (Lenexa, Kansas). Both the US and EU laboratories are situated close to our clinics to facilitate studies producing time-sensitive samples. The Lenexa facility first came on-line in October 2010, and is fully equipped with state-of-the-art bioanalytical instrumentation to provide expertise and security for your clinical samples. The Assen locations have been active since the mid-1980s to support our Phase I Clinics in Zuidlaren and Groningen and provide a benchmark for the quality of our laboratory services.
PRA's clinical facilities in The Netherlands, the United States and Central and Eastern Europe (CEE) provide 260 beds worldwide including, our specialized Unit on Demand model in CEE. PRA’s harmonized laboratory facilities in The Netherlands and the US are situated close to the clinical facilities and are configured to fully support all clinical study requirements. Our clinics are fully equipped with the technology and infrastructure required for high quality, efficient studies across a range of drugs and indications.
PRA is transforming clinical trials through our people, innovation and transparency. We have achieved a level of expertise that enables us to work across a range of compounds, from niche treatments to blockbuster drugs and biosimilars. Our Product Registration group executes complex, global Phase II-III studies for a variety of indications.
- Biostatistics and Medical Writing
- Clinical Operations
- Data Management
- Data Capture
- Data Transparency
- Data Integration
- Investigator Relations Group
- Medical Affairs
- Patient Recruitment and Retention
- Project Management
- Quality Assurance
- Regulatory Affairs
- Marketing Application Submission Services
- Investigator and Site Engagement Program
Late Phase Services:
PRA is a global expert in the design, management and implementation of post-marketing and minimal risk studies for pharmaceutical, biotech and medical device companies. Our late-phase infrastructure is designed to support your studies throughout the proving process, providing you with a dedicated, effective and knowledgeable partner to smooth the way.
Safety & Risk Management
Minimization of risk to patients has always been a top line priority in the context of new medicinal product development. Regulatory authorities now, more than ever, emphasize the importance of appropriate safety management infrastructure. The development of risk minimization strategies suitable for the whole life cycle of the medicinal product is imperative.
Markets & Strategies
PRA provides customized alternative monitoring services aligned with the FDA Clinical Trials Transformation Initiative’s and the EMA’s recommendations.
About Clinical TrialsWhat is a Clinical Trial?
A clinical trial is a research study in human volunteers to answer specific health questions. Carefully conducted clinical trials are the safest and fastest way to find treatments that work in people, and new ways to improve health.
There are different kinds of clinical trials, including those to study:
- prevention options
- new treatments or new ways to use existing treatments
- new screening and diagnostic techniques
- options for improving the quality of life for people who have serious medical conditions
Many clinical trials are done to see if a new drug or device is safe and effective for people to use. Clinical trials are also done for other reasons. Some compare existing treatments to determine which is better. The current, approved treatments are called the "standard treatments." Sometimes clinical trials are used to study different ways to use the standard treatments so they will be more effective, easier to use, and/or decrease side effects. Sometimes, studies are done to learn how to best use the treatment in a different population, such as children, in whom the treatment was not previously tested.Why Participate in a Clinical Trial?
It is important to test drugs and medical products in the people they are meant to help. It is also important to conduct research in a variety of people because different people may respond differently to treatments. Regulatory Authorities seek to ensure that people of different ages, races, ethnic groups, and genders are included in clinical trials.
Some people participate in clinical trials because they have exhausted standard (approved) treatment options - which either did not work for them, or they were unable to tolerate certain side effects. Clinical trials may provide another option when standard therapy has failed. Other people participate in trials because the want to contribute to the advancement of medical knowledge.
People should learn as much as possible about the clinical trials that interest them. Prospective participants should understand what happens during the trial, the type of health care they will receive, and any costs to them - which may or may not include the cost of the product, costs associated with administering the product, etc. Patients should feel comfortable discussing their questions and concerns with members of their health care team to determine whether or not participating in a clinical trial for their medical issue is appropriate.Information about Clinical Trials
PRA supports the willingness of patients to participate in clinical trials to not only treat their disease but to further the advancement of the field of medicine to help develop drugs that will improve the lives of future patients. To find out more, please see below links and information:
If you need assistance locating a trial for a specific medical indication, The Center for Information and Study on Clinical Research Participation (CISCRP) (www.ciscrp.org), offers a free service, Search Clinical Trials, which is an easy way to find clinical trials in your area based on your geographic location, distance willing to travel and your medical condition. Simply call 1-877-MED HERO to speak with CISCRP's staff. CISCRP will gather your information, conduct a search for you and send you the results. Searches can also be requested by filling out this form.